News from the healthcare data industry
Posted 31 March 2022 | By Ferdous Al-Faruque While the US Food and Drug Administration (FDA) began the process of modernizing its IT systems before the COVID-19 pandemic, the crisis accelerated much of that work and allowed the agency to streamline much of its activities at a critical moment in time,…
Zachary BrennanSenior EditorThe whole world watched in awe as the first two Covid-19 vaccines quickly made their way through clinical trials, offered stellar efficacy results and were quickly ushered across the FDA finish line in record time. As a result, leaders of the FDA’s Oncology Center of Excellence wrote recently…
Data being presented at the National Comprehensive Cancer Network (NCCN) 2022 Annual Conference March 31, 2022 16:05 ET | Source: G1 Therapeutics RESEARCH TRIANGLE PARK, N.C., March 31, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced results of a retrospective, observational study describing the substantial burden of…
Dr. Carl D. Marci joins OM1 to lead specialty area focused on major depression, schizophrenia, multiple sclerosis, and more BOSTON, March 31, 2022 /PRNewswire/ — OM1, a leading technology enabled real-world data and artificial intelligence (AI) company with a focus on delivering insights into multiple chronic diseases, today announces the launch of its Mental Health and…
DURHAM, N.C., March 29, 2022 /PRNewswire/ — New real-world data evaluating alanine aminotransferase (ALT) in children uncovered disparities in prevalence and severity of non-alcoholic fatty liver disease (NAFLD). The study, Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease, was published in the peer-reviewed journal Children. The data was culled from the ongoing…
March 30, 2022 06:00 PM Eastern Daylight Time AMSTERDAM–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced that the European Medicines Agency (EMA) has awarded a contract to Erasmus University Medical Center Rotterdam to provide analytics…
BELLEVUE, Wash., March 30, 2022 (GLOBE NEWSWIRE) — Truveta, the health system-led company with a vision of saving lives with data, today announced that it has obtained an ISO 27001 certification, with the ISO 27701, and ISO 27018 extensions. This certification underscores Truveta’s commitments to security, privacy, and trust. The…
Senior national security leaders to advise its US Government businessMarch 30, 2022 06:59 AM Eastern Daylight Time DENVER–(BUSINESS WIRE)–Palantir Technologies Inc. today unveiled members of its inaugural Palantir Federal Advisory Board (PFAB). This highly respected group of leaders will provide their expert perspectives on today’s defense, intelligence, and homeland security…
y Hettie Stroebel, Launch Excellence Regulatory approval usually requires definitive evidence from clinical trials. These are rooted in good study design, appropriate data collection, and thoughtful data analysis and may also be referred to as interventional trials. Interventions include, but are not restricted to, drugs, cells, and other biological products,…
In 2019, Germany passed the Digital Healthcare Act, which, among other things, created a “Fast-Track” regulatory and reimbursement pathway for digital health applications in the German market. The pathway explicitly provides for flexibility in how researchers can present evidence for new digital products, including the use of real-world data and…